Supermoon Capital invested in Lume Health, a company developing wearable continuous hormone monitoring, in a Seed round in April 2026.
APR 2026
Lume Health is developing a wearable continuous hormone monitor that uses sweat sensing to track cortisol through the skin and reveal daily hormone and circadian rhythms
Lume Health is developing a wearable continuous hormone monitor that uses sweat sensing to track cortisol through the skin and reveal daily hormone and circadian rhythms. Its product aims to help users understand patterns affecting energy, stress, sleep, and recovery, with personalized, actionable wellness insights. The company is in beta development and targets a 2027 launch.